Year archive

AIM Vaccine Co., Ltd. — 2025 filings

All 52 regulatory filings released by AIM Vaccine Co., Ltd. (6660) in 2025, sourced directly from the official regulator.

52 Filings

2025 Period

2025 filings (52)

Filing	Released	Lang
RESIGNATION OF JOINT COMPANY SECRETARY, APPOINTMENT OF COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE Board/Management Information	2025-12-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-01	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-08-27	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-02	English
CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT Board/Management Information	2025-06-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-04	English
Articles of Association Governance Information	2025-05-20	English
(1) POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON MAY 20, 2025; (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (3) DISSOLUTION OF THE SUPERVISORY COMMITTEE AND RESIGNATION OF S Declaration of Voting Results & Voting Rights Announcements	2025-05-20	English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIALS IN BOTH CHINA AND U.S. FOR ITERATIVE MRNA HERPES ZOSTER VACCINE ITS HUMORAL AND CELLULAR IMMUNITY WAS SIGNIFICANTLY HIGHER THAN THOSE OF INTERNATI Regulatory Filings	2025-05-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-07	English
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2025 AGM Information	2025-04-25	English
NOTICE OF 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-25	English
CIRCULAR OF 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-25	English
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Environmental & Social Information	2025-04-25	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-25	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Governance Information	2025-04-25	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-04-17	English
VOLUNTARY ANNOUNCEMENT - PROPOSED ADOPTION OF SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-04-17	English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF PRESIDENT OF THE GROUP Board/Management Information	2025-04-17	English
CHANGE IN COMPOSITION OF BOARD COMMITTEES Board/Management Information	2025-04-17	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-04-13	English
RESIGNATION OF DIRECTORS Board/Management Information	2025-04-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Share Issue/Capital Change	2025-04-10	English
VOLUNTARY ANNOUNCEMENT - SERUM-FREE ITERATIVE RABIES VACCINE ACCEPTED FOR MARKET REGISTRATION Regulatory Filings	2025-04-07	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Annual Report FY 2024	2025-03-28	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-27	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-03-27	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-03-27	English
VOLUNTARY ANNOUNCEMENT - APPROVAL BY THE U.S. FDA FOR CLINICAL TRIAL OF THE MRNA HERPES ZOSTER VACCINE ITS HUMORAL AND CELLULAR IMMUNITY WAS SIGNIFICANTLY HIGHER THAN THOSE OF INTERNATIONALLY COMMERCI Regulatory Filings	2025-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-18	English
VOLUNTARY ANNOUNCEMENT - SIGNIFICANT DECREASE IN LOSS OF THE COMPANY'S RESULTS Earnings Release FY 2024	2025-03-17	English
VOLUNTARY ANNOUNCEMENT - ITERATIVE SERUM-FREE RABIES VACCINE: PHASE III CLINICAL TRIALS COMPLETED, PRODUCTION LICENSE OBTAINED AND APPLICATION FOR DRUG MARKETING REGISTRATION TO BE SUBMITTED Regulatory Filings	2025-03-12	English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF THE ITERATIVE-PROCESS HIGHLY-EFFECTIVE HUMAN DIPLOID RABIES VACCINE APPROVED FURTHER CEMENTING OUR LEADING POSITION IN GLOBAL RABIES VACCINE INDUSTRY Regulatory Filings	2025-03-09	English
Next Day Disclosure Return Share Issue/Capital Change	2025-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-06	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-03-06	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-03-06	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2025-03-06	English
PLACING OF NEW H SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-02-28	English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF MRNA RESPIRATORY SYNCYTIAL VIRUS VACCINES APPROVED BY FDA WITH THEIR HUMORAL AND CELLULAR IMMUNITY SIGNIFICANTLY HIGHER THAN THOSE OF INTERNATIONALLY MARKETE Regulatory Filings	2025-02-26	English
VOLUNTARY ANNOUNCEMENT - IMMUNE INDICATORS OF THE MRNA SHINGLES/HERPES ZOSTER VACCINES WERE SIGNIFICANTLY HIGHER THAN THOSE OF INTERNATIONAL COMMERCIALLY AVAILABLE RECOMBINANT SUBUNIT VACCINES AP Regulatory Filings	2025-02-23	English
VOLUNTARY ANNOUNCEMENT - FULL INTEGRATION OF DEEPSEEK TO ACHIEVE STRATEGIC UPGRADE OF "AI + INTELLIGENT VACCINE ENTERPRISE" Regulatory Filings	2025-02-23	English
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL OF THE MRNA SHINGLES/HERPES ZOSTER VACCINES T-CELL IMMUNITY, IgG ANTIBODY TITERS AND FLUORESCENT ANTIBODY TO MEMBRANE ANTIGEN TITERS WERE S Regulatory Filings	2025-02-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
VOLUNTARY ANNOUNCEMENT - HUMORAL AND CELLULAR IMMUNITY OF THE MRNA RSV VACCINE WERE SIGNIFICANTLY HIGHER THAN THOSE OF INTERNATIONALLY MARKETED PRODUCTS APPLICATION FOR CLINICAL TRIAL IN THE U.S. Regulatory Filings	2025-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-06	English